The risk of second primary tumors after resection of stage I nonsmall cell lung cancer

Annals of Thoracic Surgery

Volumn 76, Issue 4, 2003, Pages 1001-1008

  Rice, David ^a   Kim, Hyung Woo ^a   Sabichi, Anita ^a   Lippman, Scott ^a   Lee, J Jack ^a   Williams, Brendell ^a   Vaporciyan, Ara ^a   Smythe, W Roy ^a   Swisher, Stephen ^a   Walsh, Garrett ^a   Putnam Jr , Joe B ^a   Hong, Waun Ki ^a   Roth, Jack ^a   Faber, L Penfield ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Box 445 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SECOND CANCER; SEX DIFFERENCE; SURGICAL APPROACH; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; ISOTRETINOIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES;

EID: 10744222075     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00821-X     Document Type: Article

References (25)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
3. Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg 1990;99:769-78.
4. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-8.
5. Ribet M, Dambron P. Multiple primary lung cancers. Eur J Cardiothorac Surg 1995;9:231-6.
6. van Meerbeeck J, Weyler J, Thibaut A, et al. Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis. Lung Cancer 1996;15:281-95.
7. Lippman SM, Lee JJ, Karp DD, et al. Randomized phase-III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001;93:605-18.
8. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606-11.
9. Faber LP. Resection for second and third primary lung cancer. Semin Surg Oncol 1993;9:135-41.
10. Van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 2000;92:977-86.
11. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
12. Rosengart TK, Martini N, Ghosn P, Burt M. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg 1991;52:773-8.
13. Van Bodegom PC, Wagenaar SS, Corrin B, Baak JP, Berkel J, Vanderschueren RG. Second primary lung cancer: importance of long term follow up. Thorax 1989;44:788-93.
14. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
15. Razzuk MA, Pockey M, Urschel HC Jr, Paulson DL. Dual primary bronchogenic carcinoma. Ann Thorac Surg 1974;17:425-33.
16. Aziz TM, Saad RA, Glasser J, Jilaihawi AN, Prakash D. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg 2002;21:527-33.
17. Teppo L, Salminen E, Pukkala E. Risk of a new primary cancer among patients with lung cancer of different histological types. Eur J Cancer 2001;37:613-9.
18. Boice JD Jr, Fraumeni JF Jr. Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. Natl Cancer Inst Monogr 1985;68:83-98.
19. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997;3:2237-46.
20. Levi F, Randimbison L, Te VC, La Vecchia C. Second primary cancers in patients with lung carcinoma. Cancer 1999;86:186-90.
21. Thomas PA Jr, Rubinstein L. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993;106:1053-8.
22. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-45.
23. Smith RA, Nigam BK, Thompson JM. Second primary lung carcinoma. Thorax 1976;31:507-16.
24. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997;89:1782-8.
25. Heyneman LE, Herndon JE, Goodman PC, Patz EF Jr. Stage distribution in patients with a small (≤ 3 cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening. Cancer 2001;92:3051-5.